C12Y 208/02033
N-acetylgalactosamine 4-sulfate 6-o-sulfotransferase
Official title: N-Acetylgalactosamine 4-sulfate 6-O-sulfotransferase (2.8.2.33)
C12Y208/02033 (N-acetylgalactosamine 4-sulfate 6-o-sulfotransferase) appears on 1 US grants and 8 published applications in this corpus.
Search patents in C12Y- Granted patents
- 1
- Published applications
- 8
- Assignees
- 4
- Inventors
- 6
- Latest grant
- 12 May 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2015 | 0 | 1 |
| 2016 | 0 | 1 |
| 2017 | 0 | 1 |
| 2018 | 0 | 1 |
| 2019 | 0 | 1 |
| 2020 | 1 | 1 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Pharmaceutical composition for suppressing invasion of cancer, and method for suppressing invasion of cancer13 Mar 2025US 2025/0084415 A1Tme Therapeutics Inc.
- Mucosal healing promoter15 Apr 2021US 2021/0108210 A1Stelic Institute & Co.
- Treatment of a disease of the gastrointestinal tract with a chst15 inhibitor26 Mar 2020US 2020/0094031 A1Progenity, Inc.
- Mucosal healing promoter12 Dec 2019US 2019/0376063 A1Stelic Institute & Co.
- Complex comprising rnai molecule and n-acetylated chitosan8 Nov 2018US 2018/0318430 A1Stilic Institute & Co., Inc.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.